Calpain inhibitors, a treatment for alzheimer’s disease: Position paper

Author： Battaglia Fortunato   Trinchese Fabrizio   Liu Shumin   Walter Sean   Nixon Ralph   Arancio Ottavio  

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.20, Iss.3, 2003-08, pp. : 357-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A position paper: Based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer’s disease cholesterol-lowering treatment trial (ADCLT)

By Sparks D.   Lopez Jean   Connor Don   Sabbagh Marwan   Seward Jim   Browne Patrick  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 407-410

Humana Press, Inc

Access to resources Recommend Favorite

Antioxidant treatment in alzheimer’s disease: Current state

By Gilgun-Sherki Yossi   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 21, Iss. 1, 2003-09 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite

Immunological approach for the treatment of Alzheimer’s disease

By Solomon Beka  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 283-286

Humana Press, Inc

Access to resources Recommend Favorite

Biological markers and the treatment of Alzheimer’s Disease

By Galasko Douglas  

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 119-125

Humana Press, Inc

Access to resources Recommend Favorite

Possible treatment targets in Alzheimer’s disease

By Pryce Roberts A.   Robertson N.  

Journal of Neurology, Vol. 260, Iss. 12, 2013-12 ,pp. : 3193-3196

Springer Publishing Company

Access to resources Recommend Favorite